Literature DB >> 15062086

Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches.

Cyril Dominguez1, Alexandre M J J Bonvin, G Sebastiaan Winkler, Frederik M A van Schaik, H Th Marc Timmers, Rolf Boelens.   

Abstract

The protein CNOT4 possesses an N-terminal RING finger domain that acts as an E3 ubiquitin ligase and specifically interacts with UbcH5B, a ubiquitin-conjugating enzyme. The structure of the CNOT4 RING domain has been solved and the amino acids important for the binding to UbcH5B have been mapped. Here, the residues of UbcH5B important for the binding to CNOT4 RING domain were identified by NMR chemical shift perturbation experiments, and these data were used to generate structural models of the complex with the program HADDOCK. Together with the NMR data, additional biochemical data were included in a second docking, and comparisons of the resulting model with the structure of the c-Cbl/UbcH7 complex reveal some significant differences, notably at specific residues, and give structural insights into the E2/E3 specificity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062086     DOI: 10.1016/j.str.2004.03.004

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  61 in total

1.  Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.

Authors:  Gozde Kar; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Proteome Res       Date:  2012-01-10       Impact factor: 4.466

2.  E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.

Authors:  Sarah E Soss; Yuanyuan Yue; Sirano Dhe-Paganon; Walter J Chazin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Crystal structures of two bacterial HECT-like E3 ligases in complex with a human E2 reveal atomic details of pathogen-host interactions.

Authors:  David Yin-wei Lin; Jianbo Diao; Jue Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

4.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Authors:  Hao Dou; Lori Buetow; Andreas Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

5.  PHF8 targets histone methylation and RNA polymerase II to activate transcription.

Authors:  Klaus Fortschegger; Petra de Graaf; Nikolay S Outchkourov; Frederik M A van Schaik; H T Marc Timmers; Ramin Shiekhattar
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

6.  Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.

Authors:  Jonathan Shloush; John E Vlassov; Ian Engson; Shili Duan; Vivian Saridakis; Sirano Dhe-Paganon; Brian Raught; Yi Sheng; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

7.  A structural model for the adduct between cytochrome c and cytochrome c oxidase.

Authors:  Ivano Bertini; Gabriele Cavallaro; Antonio Rosato
Journal:  J Biol Inorg Chem       Date:  2005-11-02       Impact factor: 3.358

Review 8.  Structural and functional insights to ubiquitin-like protein conjugation.

Authors:  Frederick C Streich; Christopher D Lima
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

9.  Structural and functional characterization of the monomeric U-box domain from E4B.

Authors:  Kyle A Nordquist; Yoana N Dimitrova; Peter S Brzovic; Whitney B Ridenour; Kim A Munro; Sarah E Soss; Richard M Caprioli; Rachel E Klevit; Walter J Chazin
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

10.  Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases.

Authors:  Alexander U Singer; John R Rohde; Robert Lam; Tatiana Skarina; Olga Kagan; Rosa Dileo; Nickolay Y Chirgadze; Marianne E Cuff; Andrzej Joachimiak; Mike Tyers; Philippe J Sansonetti; Claude Parsot; Alexei Savchenko
Journal:  Nat Struct Mol Biol       Date:  2008-11-09       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.